These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 27109101)

  • 21. Methylation of Aurora kinase A by MMSET reduces p53 stability and regulates cell proliferation and apoptosis.
    Park JW; Chae YC; Kim JY; Oh H; Seo SB
    Oncogene; 2018 Nov; 37(48):6212-6224. PubMed ID: 30013191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.
    Toyokawa G; Cho HS; Masuda K; Yamane Y; Yoshimatsu M; Hayami S; Takawa M; Iwai Y; Daigo Y; Tsuchiya E; Tsunoda T; Field HI; Kelly JD; Neal DE; Maehara Y; Ponder BA; Nakamura Y; Hamamoto R
    Neoplasia; 2011 Oct; 13(10):887-98. PubMed ID: 22028615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defining the NSD2 interactome: PARP1 PARylation reduces NSD2 histone methyltransferase activity and impedes chromatin binding.
    Huang X; LeDuc RD; Fornelli L; Schunter AJ; Bennett RL; Kelleher NL; Licht JD
    J Biol Chem; 2019 Aug; 294(33):12459-12471. PubMed ID: 31248990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.
    Lauring J; Abukhdeir AM; Konishi H; Garay JP; Gustin JP; Wang Q; Arceci RJ; Matsui W; Park BH
    Blood; 2008 Jan; 111(2):856-64. PubMed ID: 17942756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancer.
    Rabinowicz N; Mangala LS; Brown KR; Checa-Rodriguez C; Castiel A; Moskovich O; Zarfati G; Trakhtenbrot L; Levy-Barda A; Jiang D; Rodriguez-Aguayo C; Pradeep S; van Praag Y; Lopez-Berestein G; David A; Novikov I; Huertas P; Rottapel R; Sood AK; Izraeli S
    Oncotarget; 2017 Apr; 8(16):27380-27392. PubMed ID: 28423708
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of HDAC2 in chromatin remodelling and response to chemotherapy in ovarian cancer.
    Huang R; Langdon SP; Tse M; Mullen P; Um IH; Faratian D; Harrison DJ
    Oncotarget; 2016 Jan; 7(4):4695-711. PubMed ID: 26683361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer.
    Wei J; Costa C; Shen J; Yu L; Sanchez JJ; Qian X; Sun X; Zou Z; Gimenez-Capitan A; Yue G; Guan W; Rosell R; Liu B
    Br J Cancer; 2014 May; 110(11):2662-8. PubMed ID: 24809779
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer.
    Asangani IA; Ateeq B; Cao Q; Dodson L; Pandhi M; Kunju LP; Mehra R; Lonigro RJ; Siddiqui J; Palanisamy N; Wu YM; Cao X; Kim JH; Zhao M; Qin ZS; Iyer MK; Maher CA; Kumar-Sinha C; Varambally S; Chinnaiyan AM
    Mol Cell; 2013 Jan; 49(1):80-93. PubMed ID: 23159737
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting NSD2-mediated SRC-3 liquid-liquid phase separation sensitizes bortezomib treatment in multiple myeloma.
    Liu J; Xie Y; Guo J; Li X; Wang J; Jiang H; Peng Z; Wang J; Wang S; Li Q; Ye L; Zhong Y; Zhang Q; Liu X; Lonard DM; Wang J; O'Malley BW; Liu Z
    Nat Commun; 2021 Feb; 12(1):1022. PubMed ID: 33589584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma membrane proteomics identifies biomarkers associated with MMSET overexpression in T(4;14) multiple myeloma.
    Xie Z; Gunaratne J; Cheong LL; Liu SC; Koh TL; Huang G; Blackstock WP; Chng WJ
    Oncotarget; 2013 Jul; 4(7):1008-18. PubMed ID: 23900284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Knockdown of Histone Methyltransferase WHSC1 Induces Apoptosis and Inhibits Cell Proliferation and Tumorigenesis in Salivary Adenoid Cystic Carcinoma.
    Liu C; Jiang YH; Zhao ZL; Wu HW; Zhang L; Yang Z; Hoffman RM; Zheng JW
    Anticancer Res; 2019 Jun; 39(6):2729-2737. PubMed ID: 31177108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple-myeloma-related WHSC1/MMSET isoform RE-IIBP is a histone methyltransferase with transcriptional repression activity.
    Kim JY; Kee HJ; Choe NW; Kim SM; Eom GH; Baek HJ; Kook H; Kook H; Seo SB
    Mol Cell Biol; 2008 Mar; 28(6):2023-34. PubMed ID: 18172012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Small RNAs Recruit Chromatin-Modifying Enzymes MMSET and Tip60 to Reconfigure Damaged DNA upon Double-Strand Break and Facilitate Repair.
    Wang Q; Goldstein M
    Cancer Res; 2016 Apr; 76(7):1904-15. PubMed ID: 26822153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic
    Chong PSY; Chooi JY; Lim JSL; Toh SHM; Tan TZ; Chng WJ
    Cancer Res; 2021 May; 81(9):2332-2344. PubMed ID: 33602783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of multiple myeloma SET domain (MMSET) is associated with advanced tumor aggressiveness and poor prognosis in serous ovarian carcinoma.
    Yang S; Zhang Y; Meng F; Liu Y; Xia B; Xiao M; Xu Y; Ning X; Li H; Lou G
    Biomarkers; 2013 May; 18(3):257-63. PubMed ID: 23566000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The NSD family of protein methyltransferases in human cancer.
    Vougiouklakis T; Hamamoto R; Nakamura Y; Saloura V
    Epigenomics; 2015 Aug; 7(5):863-74. PubMed ID: 25942451
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MMSET is overexpressed in cancers: link with tumor aggressiveness.
    Kassambara A; Klein B; Moreaux J
    Biochem Biophys Res Commun; 2009 Feb; 379(4):840-5. PubMed ID: 19121287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unabridged Analysis of Human Histone H3 by Differential Top-Down Mass Spectrometry Reveals Hypermethylated Proteoforms from MMSET/NSD2 Overexpression.
    Zheng Y; Fornelli L; Compton PD; Sharma S; Canterbury J; Mullen C; Zabrouskov V; Fellers RT; Thomas PM; Licht JD; Senko MW; Kelleher NL
    Mol Cell Proteomics; 2016 Mar; 15(3):776-90. PubMed ID: 26272979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NSD2 is recruited through its PHD domain to oncogenic gene loci to drive multiple myeloma.
    Huang Z; Wu H; Chuai S; Xu F; Yan F; Englund N; Wang Z; Zhang H; Fang M; Wang Y; Gu J; Zhang M; Yang T; Zhao K; Yu Y; Dai J; Yi W; Zhou S; Li Q; Wu J; Liu J; Wu X; Chan H; Lu C; Atadja P; Li E; Wang Y; Hu M
    Cancer Res; 2013 Oct; 73(20):6277-88. PubMed ID: 23980095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HMGB1 knockdown increases MM cell vulnerability by regulating autophagy and DNA damage repair.
    Guo X; He D; Zhang E; Chen J; Chen Q; Li Y; Yang L; Yang Y; Zhao Y; Wang G; He J; Cai Z
    J Exp Clin Cancer Res; 2018 Aug; 37(1):205. PubMed ID: 30157958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.